Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00590616 · ClinicalTrials.gov registry record
Utility of Clinical Examination in the Noninvasive Prediction of Aortic Atheroma - A Prospective Study
A clinical trial, sponsored by Creighton University.
- Completed
- Registry status
- 125
- Enrollment target
NCT00590616: Completed study, sponsored by Creighton University.
NCT00590616 is a clinical trial that has completed, run by Creighton University. The registered enrollment target is 125 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00590616 has completed, sponsored by Creighton University.
- COMPLETED
- Registry status
- 125 participants
- Enrollment target
Study Summary
Aortic atheroma has been correlated with traditional cardiac risk factors, coronary, carotid, renal and peripheral atherosclerosis, and is probably a manifestation of generalized atherosclerosis. Aortic atheroma has also been shown to be associated with atrial fibrillation, aortic valve sclerosis, and other calcification of the fibrous skeleton of the heart. None of the previous studies have looked at the noninvasive prediction of aortic atheroma using the history and physical signs of cardiovascular disease. This would be a time and cost-effective bedside diagnostic tool that would be useful prior to cardiac surgery, cardiac catheterization, and workup of ischemic stroke patients, especially when transesophageal echocardiogram (TEE) is being considered for diagnosis but cannot be obtained due to previously mentioned reasons. Although physical examination of peripheral vascular disease is non-specific, a combination of physical examination signs increases the probability of generalized atherosclerosis.
Interventions
- PROCEDURE transthoracic examination
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2005-02 |
| Est. Completion | 2014-07 |
What the finished NCT00590616 record still lists
NCT00590616 is an observational study that tracks outcomes without assigning an intervention. The registered 125 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which transthoracic examination is the first listed.
NCT00590616 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00590616 about?
NCT00590616 is a clinical study titled "Utility of Clinical Examination in the Noninvasive Prediction of Aortic Atheroma - A Prospective Study". Aortic atheroma has been correlated with traditional cardiac risk factors, coronary, carotid, renal and peripheral atherosclerosis, and is probably a manifestation of generalized atherosclerosis. Aortic atheroma has also been shown to be associated with atrial fibrillation, aortic valve sclerosis, a...
What is the current status of trial NCT00590616?
This trial is currently completed. The enrollment target is 125 participants. The study started on 2005-02. Estimated completion is 2014-07.
What interventions are being tested in trial NCT00590616?
The interventions under investigation include: transthoracic examination (PROCEDURE).
Who is sponsoring clinical trial NCT00590616?
This trial is sponsored by Creighton University, which has 98 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02717039 · 125 participants
Pharmacogenomics of Heparin-Induced Thrombocytopenia
- NCT02763033 · 125 participants · Phase 2
Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients
- NCT02793999 · 125 participants
Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
- NCT03003299 · 125 participants · NA
PARTNER 3 Trial - Aortic Valve-in-Valve
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia